Crinetics Pharmaceuticals, Inc.
Status: Publicly traded
Direct answer
Crinetics Pharmaceuticals, Inc. is publicly traded on NASDAQ under the ticker CRNX.
Crinetics Pharmaceuticals, Inc. operates as a clinical-stage pharmaceutical enterprise, dedicated to the identification, advancement, and market introduction of therapeutic solutions for infrequent endocrine conditions and related tumors. Their flagship drug candidate, Paltusotine, is an orally administered, selective, non-peptide somatostatin receptor type 2 agonist. This compound has concluded its Phase III...
Can you invest in Crinetics Pharmaceuticals, Inc.?
Yes. Crinetics Pharmaceuticals, Inc. trades publicly on NASDAQ as CRNX.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Crinetics Pharmaceuticals, Inc.
Detailed equity research is provided by MarketSnap.